INTRODUCTION {#s1}
============

Many cancer cells preferentially use glycolysis for generation of ATP and metabolic intermediates even in the presence of oxygen, and such metabolic feature is regarded as a hallmark of cancer \[[@R1]\]. Normal cells show active mitochondrial respiratory function and use the energy-efficient oxidative phosphorylation as the main route to generate ATP. The phenomenon of active aerobic glycolysis in cancer cells is known as Warburg effect, and is manifested as active glucose uptake and increased lactate production \[[@R2]--[@R4]\]. Such alterations in energy metabolism in cancer cells are often associated with mitochondrial dysfunction \[[@R5]\]. Importantly, recent studies suggest that metabolic alterations in cancer cells seem to be associated with activation of certain oncogenic signals (such as activating mutations in Ras oncogene) or loss of tumor suppressor function (such as loss or mutation of p53). Of note, the oncogenic Ras proteins including K-Ras, H-Ras and N-Ras are frequently mutated in human cancers. K-Ras is normally associated with the membrane lipid rafts and acts as an effector for signal transduction. Recent studies showed that K-Ras is able to translocate to mitochondria when phosphorylated \[[@R6]\]. Other studies showed that K-Ras is able to cause mitochondria dysfunction and regulate glucose metabolism \[[@R7]--[@R9]\], yet the detailed molecular mechanisms of mitochondria dysfunction induced by K-Ras remains to be investigated.

Recent advance in proteomic technology has enabled detail analysis of protein molecules that contribute to metabolic alterations in cancer and other diseases. Application of mitochondrial proteomics has shed new light on diagnosis and treatment of mitochondria dysfunction associated diseases, and allowed identification and quantification of biomarkers for the early diagnosis and pathologies \[[@R10], [@R11]\]. Stable isotope labeling with amino acids (SILAC) has become a pivotal tool to study changes in protein abundance in many different biological processes such as detection of biomarkers in tissue samples, the regulation of cell signaling, and the characterization of protein interactions. The current study used SILAC technology as initial screening for candidate proteins involved in mitochondrial dysfunction induced by K-Ras activating mutation (K-Ras^G12V^).

The main goals of this study were to identify mitochondrial proteins that may be involved in the metabolic alterations induced by constitutive activation of K-Ras, to investigate underlying mechanism, and to evaluate the clinical relevance. We have previously established a doxycycline inducible cell system with K-Ras^G12V^ expression vector (T-Rex/293), which induced mitochondrial dysfunction upon expression of K-Ras^G12V^ protein \[[@R9]\]. Since abnormal K-Ras activation and the associated mitochondrial dysfunction and metabolic shift are frequently observed in human cancer, the use of the current experimental system enabled us to identify a key molecular player that seems essential to maintain the metabolic changes in K-Ras-transformed cells. In this study, we isolated mitochondria from T-Rex/293 cells before and after induction of K-Ras^G12V^, followed by identification of mitochondrial proteins with significant changes using SILAC coupled with LC-MS analysis. A number of subunits of mitochondrial respiratory chain complex I were identified with significantly decreased protein ratios. We found that NDUFAF1 showed the most significant decrease after K-Ras^G12V^ induction and such decrease was also observed in clinical samples of pancreatic cancer tissues. The role of NDUFAF1 decrease in mediating mitochondrial dysfunction was further confirmed by siRNA knockdown, which led to inhibition of mitochondrial complex I activity and up-regulation of glycolysis.

RESULTS {#s2}
=======

K-Ras activation causes mitochondrial dysfunction {#s2_1}
-------------------------------------------------

We have previously established a tetracycline-inducible K-Ras^G12V^ expression cell system \[[@R9]\]. In this system, expression of K-Ras^G12V^ protein can be induced by addition of doxycycline and a large portion of K-Ras^G12V^ protein is localized to the mitochondria, leading to changes of mitochondrial function (9). Since mitochondria play a critical role in carrying out oxidative phosphorylation and normally produces the majority of cellular ATP, we first measured ATP generation and oxygen consumption before and after K-Ras^G12V^ induction. As shown in Figure [1A](#F1){ref-type="fig"}, K-Ras^G12V^ expression caused a decrease of ATP generation in a time-dependent manner. Mitochondrial respiratory chain activity was also inhibited as evidenced by substantial decrease in oxygen consumption rate after K-Ras activation for both 24 hrs and 48 hrs (Figure [1B](#F1){ref-type="fig"}). The Seahorse XF analyser further demonstrated that K-Ras activation caused significant decrease in both maximal respiration and basal respiration levels ([Supplemental Figure 1](#SD1){ref-type="supplementary-material"}). One important biochemical event associated with oxidative phosphorylation is the production of reactive oxygen species (ROS) due to electron leakage from the respiratory chain. We found that K-Ras activation resulted in an increase of ROS production detected by DCF-DA (Figure [1C](#F1){ref-type="fig"}). Substantial elevation of intracellular superoxide (O~2~^−^) was also detected by MitoSOX Red mitochondrial superoxide indicator ([Supplemental Figure 2A](#SD1){ref-type="supplementary-material"}), indicating the source of ROS generation form mitochondrial electron leakage. We also examined the ultrastructure of mitochondria by transmission electron microscope (TEM). Normal tubular morphology of mitochondria was observed in control cells without K-Ras induction (Figure [1D](#F1){ref-type="fig"}). In contrast, swollen mitochondria were seen after K-Ras induction for 24 hrs (Figure [1E](#F1){ref-type="fig"}). Rotenone, a known inhibitor of mitochondrial respiratory chain complex I was used to treat the cells without K-Ras induction. As shown in Figure [1F](#F1){ref-type="fig"}, incubation with 100 nM rotenone for 36 h also caused alterations of mitochondrial morphology similar to that of cells with K-Ras^G12V^ induction. Taken together, these results suggest that K-Ras activation is able to cause significant alterations in mitochondrial function and ultrastructure.

![Expression of oncogenic K-Ras^G12V^ caused mitochondria dysfunction and metabolic alterations\
**(A)** ATP levels of T-Rex/293 cells before and after K-Ras^G12V^ induction by doxycycoine for 24 and 48 hrs. Data are shown as mean ± SD from three independent experiments, \**P* \< 0.05. **(B)** Decrease of oxygen consumption rate after K-Ras^G12V^ induction for 24 and 48 hrs. **(C)** Increase of ROS level after K-Ras induction for 24 and 48 hrs detected by flow cytometry using DCF-DA. **(D--F)** Transmission electron microscopic analysis of mitochondria morphology. **(D)** Normal mitochondrial morphology of TRex/293 cell without K-Ras activation. **(E)** Alteration of mitochondrial morphology after K-Ras induction for 48 hrs. **(F)** Alteration of mitochondrial morphology after treatment of 100 nM rotenone for 36 hrs.](oncotarget-06-3947-g001){#F1}

Proteomic analysis of mitochondrial proteins using SILAC {#s2_2}
--------------------------------------------------------

To identify the potential mitochondrial proteins involved in mediating mitochondrial dysfunction induced by K-Ras, we used quantitative proteomics to analyze mitochondria proteome dynamics using stable isotope labeling with amino acids in cell culture (SILAC). In consistence with our previous finding that K-Ras protein was associated with mitochondria, western blotting analysis confirmed the increase of K-Ras^G12V^ expression in a time-dependent manner in the mitochondrial fraction after addition of doxycyline (Figure [2A](#F2){ref-type="fig"}). The purity of mitochondria was validated by organelle specific protein markers of different subcellular fractions. As shown in Figure [2B](#F2){ref-type="fig"}, after induction for 24 hrs, the mitochondrial fraction was highly enriched in mitochondrial markers such as VDAC (Voltage-dependent anion channel) and cytochrome C, while other markers such as tubulin (cytosol marker) and Bip (endoplasmic reticulum marker) were absent in the mitochondrial fraction, indicating that there was no detectable contamination of other organelles.

![SILAC analysis of mitochondrial proteome in cells with and without K-Ras^G12V^ expression\
**(A)** Expression of K-Ras^G12V^ in mitochondria after doxycycline induction for 24 and 48 hrs. Cytochrome C was used as loading control for mitochondria extracts. **(B)** Purity of mitochondrial protein extracts by immunoblotting analysis. Cellular fractions were prepared from T-Rex/293 cells after K-Ras activation for 24 hrs. Purity of subcellular fractions was determined by immunoblotting analysis using antibodies against mitochondrial localized marker VDAC and cytochrome C, cytoplasmic localized marker α-tubulin, ER (endoplasmic reticulum) localized marker Bip. **(C)** Quantification and identification of mitochondrial proteins of T-Rex/293 cells before and after K-Ras induction by LC-MS. Cells were labeled with different isotopes as described in "Experimental procedures" under "Cell culture and isotopes labeling". Light, control cells without K-Ras induction. Medium and Heavy, cells with K-Ras induction for 24 hrs and 48 hrs, respectively. The mixed mitochondrial lysates were separated by SDS-PAGE and analyzed by Mass Spectrometry. **(D)** The mass spectrum peaks indicates the separation of mitochondrial proteins labeled with different isotopes.](oncotarget-06-3947-g002){#F2}

Figure [2C](#F2){ref-type="fig"} depicts the proteomic strategy using SILAC and LC-MS for discovery of changes in mitochondrial proteins associated with metabolic alteration induced by K-Ras. The T-Rex/K-Ras cells with and without K-Ras induction were labeled with the indicated stable isotopes and cultured for 10 passages before protein isolation and LC-MS analyses. Control cells without K-Ras induction were cultured in isotope free medium (light density, K~0~R~0~). Cells with K-Ras induction for 24 hrs were cultured in \[^13^C~6~\]arginine and 4,4,5,5-D4-lysine labeled medium (Medium density, K~4~R~6~). Cells with K-Ras induction for 48 hrs were cultured in \[^13^C~6~,^15^N~4~\]arginine and \[^13^C~6~,^15^N~2~\]lysine labeled medium (Heavy density, K~8~R~10~). Mitochondria isolated from cells labeled with light, medium and heavy isotopes were mixed in a 1:1:1 ratio based on total protein concentrations. The mixed mitochondria were then lysed, properly digested to peptides, and then subjected to LC-MS/MS analysis. As shown in Figure [2D](#F2){ref-type="fig"}, the mass spectrum peaks of heavy and medium labeled proteins exhibited a corresponding shift according to their m/z values compared with light proteins, indicating proper incorporation of isotopes into the cells with different status of K-Ras as anticipated.

Identification of K-Ras-induced alterations in mitochondrial proteins {#s2_3}
---------------------------------------------------------------------

The mass spectrum analysis was used to characterize and quantify the mitochondrial proteomic changes induced by K-Ras^G12V^. As shown in Figure [3A](#F3){ref-type="fig"}, 614 mitochondria proteins were identified and quantified by LC-MS and SILAC. 544 mitochondrial proteins remained unchanged after K-Ras induction. 33 proteins showed a significantly increase and 37 proteins showed a significant decrease when compared with the control sample without K-Ras induction. Among the 33 proteins with increased expression, 5 proteins were upregulated only at the early time point (24 h); 15 proteins increased only at 48 h; and 13 proteins were upregulated at both 24 h and 48 h. Among the 37 proteins with lower expression, 4 proteins were downregulated at 24 h; 10 proteins were downregulated only after 48 hrs, and 23 proteins decreased at both 24 h and 48 h.

![Effect of K-Ras^G12V^ activation on mitochondrial proteins expression profiles\
**(A)** Venn diagrams depict 614 proteins identified and quantified by SILAC and LC-MS. 544 proteins remained unchanged. 70 proteins showed significantly altered expression in cells with K-Ras induction for 24 or 48 hrs compared with control without K-Ras induction (*P* \< 0.05). **(B--D)** Volcano plots showing protein ratios of each pair of cells indicated. H, K-Ras induction for 48 hrs. M, K-Ras induction for 24 hrs. L, control without K-Ras induction.](oncotarget-06-3947-g003){#F3}

The protein density ratios (Figure [3B--3D](#F3){ref-type="fig"}) represent the relative abundance of proteins in cells with K-Ras induction compared with cells without induction (H/L for 48 h, M/L for 24 h), or cells with 48 hr induction compared with cells with 24 hr induction (H/M). The majority of proteins remained unchanged with the density distribution at 1:1 ratio. A small number of proteins showed significant change (*P* \< 0.05), and suggested a possibility that these mitochondrial proteins might contribute to the mitochondrial dysfunction and metabolic alterations induced by K-Ras activation. As shown in Table [1](#T1){ref-type="table"}, K-Ras was identified in the mitochondrial proteome and its expression increased by 5.2 and 7.3 folds after induction for 24 and 48 hs, respectively ("M&H higher", line 12). This was consistent with the findings in Figure [2A](#F2){ref-type="fig"} showing the increase of K-Ras protein in mitochondria, and thus served as a good validation of this proteomic analysis. We then used Panther (protein analysis through evolutionary relationships) analysis to investigate the biological pathways involved after K-Ras activation. As shown in Table [2](#T2){ref-type="table"}, we identified 13 groups of proteins based on the biological function of these differentially expressed proteins after K-Ras induction. Of particular note, among the approximately 70 mitochondrial proteins that showed altered expression after K-Ras induction, 9 proteins are involved in generation of metabolite and energy precursors and 36 proteins are associated with metabolic process (Table [2](#T2){ref-type="table"} lines 9 and 10, respectively).

###### Differential expression of mitochondrial proteins after K-ras activation

  Protein IDs   Protein Names                                                   Gene Names   Ratio M/L Normalized   Ratio M/L *p*-value   Ratio H/L Normalized   Ratio H/L *p*-value
  ------------- --------------------------------------------------------------- ------------ ---------------------- --------------------- ---------------------- ---------------------
  M&H higher                                                                                                                                                     
  IPI00024551   UPF0480 protein C15orf24                                        C15orf24     2.405                  0.005                 1.998                  0.049
  IPI00784366   AP-2 complex subunit beta-1                                     AP2B1        1.954                  0.026                 2.338                  0.021
  IPI00059762   Lysophospholipase-like protein 1                                LYPLAL1      3.416                  0.001                 2.352                  0.021
  IPI00908804   highly similar to ATP-binding cassette sub-family D member 3    ABCD3        2.444                  0.005                 2.319                  0.022
  IPI00294472   Transmembrane emp24 domain-containing protein 5                 TMED5        2.075                  0.017                 2.029                  0.045
  IPI00328840   THO complex subunit 4                                           THOC4        1.882                  0.034                 2.069                  0.041
  IPI00305289   Kinesin-like protein KIF11                                      KIF11        2.104                  0.015                 2.409                  0.018
  IPI00215637   ATP-dependent RNA helicase DDX3X                                DDX3X        1.806                  0.044                 2.082                  0.040
  IPI00018246   Hexokinase-1                                                    HK1          2.727                  0.002                 3.268                  0.002
  IPI00879004   DNA topoisomerase 2-alpha                                       TOP2A        2.374                  0.006                 2.753                  0.008
  IPI00034159   V-type proton ATPase subunit d 1                                ATP6V0D1     1.803                  0.045                 2.069                  0.041
  IPI00423570   GTPase Kras                                                     KRAS         5.210                  0.001                 7.269                  0.001
  IPI00293073   Mitofusin-1                                                     MFN1         0.696                  0.035                 4.734                  0.001
  H higher                                                                                                                                                       
  IPI00031691   60S ribosomal protein L9                                        RPL9         1.737                  0.056                 2.107                  0.037
  IPI00419258   High mobility group protein B1protein B1                        HMGB1        1.755                  0.053                 2.061                  0.042
  IPI00026111   Transmembrane and coiled-coil domain-containing protein 1       TMCO1        1.599                  0.090                 2.060                  0.042
  IPI00376377   Dehydrogenase/reductase (SDR family) member 2                   DHRS2        1.493                  0.128                 2.076                  0.040
  IPI00374657   Putative uncharacterized protein VAPA                           VAPA         1.637                  0.079                 2.162                  0.033
  IPI00418169   Putative uncharacterized protein DKFZp686P03159                 ANXA2        1.395                  0.175                 2.468                  0.016
  IPI00293564   Hydroxymethylglutaryl-CoA lyase, mitochondrial                  HMGCL        1.032                  0.485                 3.781                  0.001
  IPI00554481   4F2 cell-surface antigen heavy chain                            SLC3A2       1.611                  0.086                 2.490                  0.015
  IPI00329600   Probable saccharopine dehydrogenase                             SCCPDH       1.271                  0.256                 2.036                  0.044
  IPI00293845   Telomere-associated protein RIF1                                RIF1         1.490                  0.129                 2.301                  0.023
  IPI00478810   Ribosomal protein S10                                           RPS10        0.928                  0.328                 2.279                  0.025
  IPI00293260   DnaJ homolog subfamily C member 10                              DNAJC10      1.453                  0.145                 2.059                  0.042
  IPI00003856   V-type proton ATPase subunit E 1                                ATP6V1E1     1.557                  0.103                 5.208                  0.001
  IPI00306667   2′,3′-cyclic-nucleotide 3′-phosphodiesterase                    CNP          1.335                  0.210                 6.639                  0.001
  M higher                                                                                                                                                       
  IPI00418414   Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial    COQ3         10.682                 0.001                 1.407                  0.204
  IPI00644079   Heterogeneous nuclear ribonucleoprotein U                       HNRNPU       1.833                  0.040                 1.660                  0.111
  IPI00604590   Nucleoside diphosphate kinase                                   NME1-NME2    3.010                  0.001                 1.376                  0.219
  IPI00005202   Membrane-associated progesterone receptor component 2           PGRMC2       2.794                  0.001                 1.936                  0.057
  IPI00291939   Structural maintenance of chromosomes protein 1A                SMC1A        2.020                  0.021                 1.527                  0.153
  H&M down                                                                                                                                                       
  IPI00456965   Ubiquinone biosynthesis methyltransferase COQ5, mitochondrial   COQ5         0.641                  0.014                 0.479                  0.006
  IPI00015808   Nucleolar GTP-binding protein 2                                 GNL2         0.490                  0.001                 0.286                  0.001
  IPI00293975   Glutathione peroxidase 1                                        GPX1         0.678                  0.026                 0.596                  0.038
  IPI00893857   NADH dehydrogenase 1 alpha subcomplex subunit 11                NDUFA11      0.615                  0.008                 0.478                  0.006
  IPI00020050   Probable ATP-dependent RNA helicase DDX28                       DDX28        0.716                  0.047                 0.498                  0.008
  IPI00026512   GTP-binding protein era homolog                                 ERAL1        0.644                  0.015                 0.418                  0.001
  IPI00847172   Peripheral-type benzodiazepine receptor                         PBR          0.589                  0.005                 0.473                  0.005
  IPI00032872   28S ribosomal protein S16, mitochondrial                        MRPS16       0.695                  0.035                 0.568                  0.027
  IPI00005966   NADH dehydrogenase 1 alpha subcomplex subunit 12                NDUFA12      0.662                  0.020                 0.554                  0.021
  IPI00219772   NADH dehydrogenase 1 beta subcomplex subunit 7                  NDUFB7       0.679                  0.027                 0.578                  0.030
  IPI00470631   Ubiquinone biosynthesis protein COQ9, mitochondrial             COQ9         0.708                  0.042                 0.546                  0.019
  IPI00290614   Endonuclease G, mitochondrial                                   ENDOG        0.609                  0.007                 0.537                  0.016
  IPI00514501   Chromosome 1 open reading frame 57                              C1orf57      0.693                  0.034                 0.546                  0.019
  IPI00333763   Glutaredoxin-related protein 5                                  GLRX5        0.584                  0.004                 0.545                  0.019
  IPI00024742   Cytochrome b-c1 complex subunit 8                               UQCRQ        0.674                  0.025                 0.599                  0.040
  IPI00176469   Chaperone activity of bc1 complex-like, mitochondrial           CABC1        0.502                  0.000                 0.593                  0.037
  IPI00010244   28S ribosomal protein S11, mitochondrial                        MRPS11       0.571                  0.003                 0.553                  0.021
  IPI00023673   Galectin-3-binding protein                                      LGALS3BP     0.486                  0.001                 0.494                  0.008
  IPI00890773   Protein MTO1 homolog, mitochondrial                             MTO1         0.642                  0.014                 0.559                  0.023
  IPI00738524   General transcription factor IIH subunit 2-like protein         GTF2H2       0.014                  0.001                 0.134                  0.001
  IPI00021785   Cytochrome c oxidase subunit 5B, mitochondrial                  COX5B        0.610                  0.007                 0.615                  0.048
  IPI00152685   Tetratricopeptide repeat protein 15                             TTC15        0.643                  0.014                 0.497                  0.008
  IPI00219381   NADH dehydrogenase 1 alpha subcomplex subunit 2                 NDUFA2       0.458                  0.001                 0.549                  0.020
  H down                                                                                                                                                         
  IPI00448630   Sterile alpha and TIR motif-containing protein 1                SARM1        1.096                  0.415                 0.591                  0.036
  IPI00032560   Complex I intermediate-associated protein 30                    NDUFAF1      0.876                  0.235                 0.503                  0.009
  IPI00013679   Deoxyuridine 5′-triphosphate nucleotidohydrolase                DUT          0.868                  0.223                 0.491                  0.007
  IPI00217081   FUN14 domain-containing protein 1                               FUNDC1       0.855                  0.202                 0.559                  0.023
  IPI00419626   39S ribosomal protein L55, mitochondrial                        MRPL55       1.201                  0.312                 0.599                  0.040
  IPI00167638   GTP-binding protein 10                                          GTPBP10      0.782                  0.105                 0.600                  0.040
  IPI00217871   Delta-1-pyrroline-5-carboxylate dehydrogenase                   ALDH4A1      0.993                  0.451                 0.594                  0.038
  IPI00008483   Amine oxidase A                                                 MAOA         0.800                  0.126                 0.547                  0.019
  IPI00037448   Glyoxylate reductase/hydroxypyruvate reductase                  GRHPR        0.902                  0.280                 0.596                  0.038
  IPI00011276   2-oxoisovalerate dehydrogenase subunit beta                     BCKDHB       0.729                  0.056                 0.560                  0.023
  M down                                                                                                                                                         
  IPI00016443   Protein EMI5 homolog, mitochondrial                             C11orf79     0.433                  0.001                 0.830                  0.269
  IPI00830136   Uncharacterized protein C1orf31                                 C1orf31      0.692                  0.033                 1.025                  0.468
  IPI00215790   60S ribosomal protein L38                                       RPL38        0.647                  0.015                 1.191                  0.332
  IPI00879060   2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial         GCAT         0.650                  0.016                 1.198                  0.327

H (K-ras induction for 48 hrs), M (K-ras induction for 24 hrs), L (control without induction).

###### Percentage of identified mitochondrial proteins based on their biological functions

       Category name (Accession)                                     Counts   Percent of total genes
  ---- ------------------------------------------------------------- -------- ------------------------
  1    Cell communication (GO:0007154)                               8        11.60%
  2    Cellular process (GO:0009987)                                 14       20.30%
  3    Transport (GO:0006810)                                        13       18.80%
  4    Cellular component organization (GO:0016043)                  1        1.40%
  5    Apoptosis (GO:0006915)                                        3        4.30%
  6    System process (GO:0003008)                                   1        1.40%
  7    Response to stimulus (GO:0050896)                             2        2.90%
  8    Developmental process (GO:0032502)                            2        2.90%
  9    Generation of precursor metabolites and energy (GO:0006091)   9        13.00%
  10   Metabolic process (GO:0008152)                                36       52.20%
  11   Cell cycle (GO:0007049)                                       4        5.80%
  12   Immune system process (GO:0002376)                            3        4.30%
  13   Cell adhesion (GO:0007155)                                    4        5.80%

Because K-Ras activation caused a significant decrease in cellular oxygen consumption and ATP production (Figure [1](#F1){ref-type="fig"}), we further analyzed the group of 9 proteins involved in the generation of precursor metabolites and energy in order to identify the mitochondrial proteins contributing to K-Ras-induced metabolic alterations. Out of the 9 proteins in this group, 5 proteins belonged to the mitochondrial respiratory chain complex I, one protein was a subunit of complex III, and one belonged to complex IV (Table [3](#T3){ref-type="table"}).

###### Differential expression of mitochondrial respiratory chain subunits after K-ras induction for 48 hrs

  Protein IDs   Gene Names   Protein description                                        Mitochondria location   Ratio H/L Normalized   Ratio H/L *p* value
  ------------- ------------ ---------------------------------------------------------- ----------------------- ---------------------- ---------------------
  IPI00032560   NDUFAF1      NADH dehydrogenase 1 alpha subcomplex, assembly factor 1   Complex I               0.50267                0.01
  IPI00893857   NDUFA11      NADH dehydrogenase 1 alpha subcomplex subunit11            Complex I               0.47817                0.01
  IPI00219381   NDUFA2       NADH dehydrogenase 1 alpha subcomplex subunit 2            Complex I               0.54878                0.02
  IPI00005966   NDUFA12      NADH dehydrogenase 1 alpha subcomplex subunit 12           Complex I               0.55382                0.02
  IPI00219772   NDUFB7       NADH dehydrogenase 1 beta subcomplex subunit 7             Complex I               0.578                  0.03
  IPI00024742   UQCRQ        Complex III subunit 8                                      Complex III             0.59858                0.04
  IPI00021785   COX5B        Cytochrome c oxidase subunit 5B, mitochondria              Comolex IV              0.6149                 0.04

Down regulation of NDUFAF1 in K-Ras-transformed cells and in pancreatic cancer tissues {#s2_4}
--------------------------------------------------------------------------------------

The results shown in Table [3](#T3){ref-type="table"} suggest that down-regulation of certain complex I components, especially NADH dehydrogenase (ubiquinone) 1 alpha sub-complex assembly factor 1 (NDUFAF1), might play an important role in mediating mitochondrial dysfunction induced by K-Ras activation, since the expression of these protein subunits were significantly down-regulated. It is known that NDUFAF1 plays a key role in the assembly of mitochondrial complex I \[[@R12]--[@R14]\]. LC-MS analysis showed that the expression of NDUFAF1 was down-regulated by approximately 20% and 50% after K-Ras induction for 24 hrs and 48 hrs, respectively (Figure [4A](#F4){ref-type="fig"}). Western blot analysis also demonstrated a significant decrease of NDUFAF1 expression after K-Ras induction at both time points (24 and 48 h), and such decrease was consistently observed in cells with long-term (\>1 month) K-Ras induction (Figure [4B](#F4){ref-type="fig"}). Importantly, doxycycline induced K-Ras*^G12V^* expression in a dose-dependent manner, and the level of NDUFAF1 protein decreased as the expression of K-Ras increased. In addition, K-Ras expression caused a decrease in NDUFAF1 protein under hypoxia condition, which mimics the tumor microenvironment ([Supplemental Figure 1](#SD1){ref-type="supplementary-material"}). The expression of NDUFAF1 was also tested in K-Ras transformed human pancreatic ductal epithelial (HPDE/K-Ras) cells established previously \[[@R15]\], and the immunoblotting results showed that NDUFAF1 was significantly decrease in the transformed cells compared with the non-transformed parental HPDE cells (Figure [4B](#F4){ref-type="fig"}, lower panel).

![Suppression of NDUFAF1 expression by K-Ras^G12V^ and its low expression in pancreatic cancer tissues\
**(A)** Quantification of NDUFAF1 proteins by mass spectrum from three samples. L, control without K-Ras induction. M, K-Ras induction for 24 hrs. H, K-Ras induction for 48 hrs. **(B)** Westernblot detection of NDUFAF1 protein in T-Rex/293 cells before and after K-Ras induction and comparison of NDUFAF1 protein in the K-Ras transformed human pancreatic ductal epithelial (HPDE) cells and the parental control. Long, K-Ras induction \>1 month. **(C)** Representative immunohistochemical staining of tissue microarray showing NDUFAF1 expression is significantly down regulated in pancreatic cancer tissues. Left panel, normal pancreatic duct; Right panel, pancreatic ductal carcinoma. The comparison of NDUFAF1 expression between normal and cancer tissue was analyzed with Fisher\'s exact test, *P* \< 0.05. *n* = 80.](oncotarget-06-3947-g004){#F4}

Considering that oncogenic mutations of K-Ras are frequently observed in the vast majority of human pancreatic cancer cases \[[@R16]\], we next tested if the findings from our proteomic analysis in cell lines could be verified in pancreatic tumor samples, using a pancreatic cancer tissue arrays containing 80 pairs of pancreatic ductal carcinoma and the adjacent normal pancreatic tissues. As shown in Figure [4C](#F4){ref-type="fig"}, immunohistochemical analysis revealed that the majority 64% (51/80) of the pancreatic cancer tissues exhibited low expression of NDUFAF1. In contrast, the majority of the adjacent normal pancreatic tissues 61% (49/80) showed high expression of NDUFAF1. Overall, there was a statistically lower expression of NDUFAF1 in pancreatic carcinoma than in normal pancreatic tissues (*P* \< 0.05, Fisher\'s exact test), suggesting that a decrease in NDUFAF1 expression may be clinically relevant in pancreatic cancer.

Role of NDUFAF1 down-regulation in mediating mitochondrial dysfunction induced by K-Ras {#s2_5}
---------------------------------------------------------------------------------------

To further test the functional consequence of NDUFAF1 down-regulation, we used siRNA to specifically knock down the expression of NDUFAF1 in T-Rex/293 cells. As shown in Figure [5A](#F5){ref-type="fig"}, siRNA against NDUFAF1 effectively suppressed its expression, leading to a significant decrease of the activity of mitochondrial respiratory chain complex I. Because NDUFAF1 is a complex I assembly factor, a Blue-native Polyacrylamide Gel Electrophoresis (BN-PAGE) was performed to detect the effect of knockdown of NDUFAF1 or K-Ras activation. Both K-Ras activation and knockdown of NDUFAF1 mainly inhibited the assembly of complex I ([Supplemental Figure 3](#SD1){ref-type="supplementary-material"}). As a result, the mitochondrial respiratory chain activity was significantly inhibited, as evidenced by a decrease in oxygen consumption rate (Figure [5B](#F5){ref-type="fig"}). Because mitochondrial respiratory chain is the major site of ATP generation and reactive oxygen species (ROS) production, we also analyzed the possible metabolic alterations after NDUFAF1 knockdown. Suppression of NDUFAF1 expression by siRNA caused a significant decrease in ATP generation (Figure [5C](#F5){ref-type="fig"}) and a substantial increase of ROS level detected by both DCF-DA (Figure [5D](#F5){ref-type="fig"}) and MitoSOX ([Supplemental Figure 2B](#SD1){ref-type="supplementary-material"}). Taken together, these data suggest that suppression of NDUFAF1 expression could cause significant mitochondrial dysfunction.

![Knockdown of NDUFAF1 causes mitochondrial dysfunction\
**(A)** Inhibition of mitochondrial respiratory chain complex I activity by knockdown of NDUFAF1. Data are shown as mean ± SD, \**P* \< 0.05. Western blot analysis showing knockdown efficiency of NDUFAF1. Non-targeting control siRNA (Scram) was used as control. **(B)** Decrease of oxygen consumption rate after knockdown of NDUFAF1. **(C)** Decrease of ATP production after NDUFAF1 knockdown, \**P* \< 0.05. **(D)** Detection of ROS level before and after knockdown of NDUFAF1 by flow cytometry using CM-DCFDA.](oncotarget-06-3947-g005){#F5}

We then further analyzed the effect of K-Ras-mediated mitochondrial dysfunction on glycolytic activity. Figure [6A](#F6){ref-type="fig"} shows a significant elevation of glycolytic activity in T-Rex/293 cells after short-term (24--48 h) or long term (\>1 month) induction of K-Ras expression. Since our mitochondrial proteomic analysis identified NDUFAF1 as an important protein suppressed by K-Ras, we tested if knockdown of NDUFAF1 could also cause increase of glycolytic activity. In agreement with the metabolic alterations induced by K-Ras, suppression of NDUFAF1 expression also caused a significant increase in glycolysis, as revealed by the increase in glucose uptake and lactate production (Figure [6B](#F6){ref-type="fig"}). To further confirm that the increased of glycolysis is a consequence of mitochondrial dysfunction, we used rotenone, a specific inhibitor of mitochondria complex I, to test its effect on glycolysis. As shown in Figure [6C](#F6){ref-type="fig"}, incubation of T-Rex/293 cells with 10 nM rotenone for 12 hrs caused a significant increase in glucose uptake and lactate production, comparable to that seen in the T-Rex/293 cells with NDUFAF1 knockdown by siRNA (Figure [6B](#F6){ref-type="fig"}).

![Mitochondrial dysfunction leads to increase of glycolysis activity and accumulation of NADH in T-Rex/293 cells\
**(A--B)** K-Ras activation and knockdown of NDUFAF1 caused increase of glycolytic activity as measured by glucose uptake and lactate production. Long, K-Ras induction for more than 1 month by addition of doxycycline. **(C)** Inhibitor of mitochondrial respiratory chain complex I by rotenone (10 nM) caused increase of glycolytic activity in TRex/293 cells. **(D)** Oxygen consumption remained inhibited after long term induction of K-Ras (\>1 month). **(E)** ATP production remained unchanged after long term induction of K-Ras. **(F--G)** Activation of K-Ras for 24 h and knockdown of NDUFAF1 caused increase of NADH generation.](oncotarget-06-3947-g006){#F6}

The above results showed that acute induction of K-Ras caused mitochondrial dysfunction and metabolic switch to glycolysis. We then further analyzed the metabolic state of cells after long-term induction of K-Ras. Mitochondrial respiratory chain activity remained inhibited in T-Rex/293 cells with continuous induction of K-Ras for more than 1 month (Figure [6D](#F6){ref-type="fig"}), while glycolytic activity also remained upregulated (Figure [6A](#F6){ref-type="fig"}, column indicated with "long"). Interestingly, in contrast to the acute ATP decrease after K-Ras induction for 24--48 hrs, the cellular ATP level recovered to normal levels after long-term induction of K-Ras for more than 1 month (Figure [6E](#F6){ref-type="fig"}), suggesting the eventual metabolic adaptation that compensate ATP generation.

NADH is the main substrate for mitochondrial respiratory chain, and mitochondrial dysfunction could cause an accumulation of NADH. NADH is required for regeneration of NAD^+^, which is important to maintain active glycolysis \[[@R17]\]. Indeed, we observed that activation of K-Ras for 24 hrs (Figure [6F](#F6){ref-type="fig"}) or suppression of NDUFAF1 by siRNA (Figure [6G](#F6){ref-type="fig"}) led to an increase of NADH by approximately 20% in T-Rex/293 cells. Together, these data suggest that down-regulation of NDUFAF1 might be an important event contributing to K-Ras-induced mitochondrial dysfunction and increase in glycolysis.

DISCUSSION {#s3}
==========

K-Ras represents the most frequent mutation during malignant transformation and cancer development \[[@R18]\]. Increasing evidence suggests a strong association between oncogenic transformation and metabolic alterations including mitochondrial dysfunction and upregulation of aerobic glycolysis \[[@R8], [@R19], [@R20]\]. Our previous study demonstrated that activation of mutated K-Ras (G12V) inhibited the function of mitochondrial respiratory chain, leading to an increase of glycolytic activity \[[@R9]\]. In order to thoroughly understand the molecular mechanisms associated with K-Ras oncogenic signaling and alterations in cellular metabolism, the current study used a subcellular proteomic strategy to identify changes of proteins in the mitochondria of K-Ras transformed cells with SILAC/LC-MS analysis.

By comparing the mitochondrial proteome of T-Rex/293 cells before and after K-Ras induction in the doxycyline inducible cell system, we were able to detect 614 mitochondrial proteins, and among them we identified 70 proteins with significant altered abundance. The biological function analysis revealed that 65% of the altered mitochondrial proteins were associated with generation of metabolites and metabolic process. Intriguingly, we found that 7 out of the 70 proteins with change in expression were subunits of the mitochondrial respiratory chain complexes, and 5 out of 7 subunits identified belong to complex I.

Mitochondria are the major source of cellular ATP production. The mitochondrial respiratory chain produces ATP through oxidative phosphorylation. Complex I (NADH dehydrogenase) initiates the electron transportation by oxidizing NADH to NAD^+^. Our results showed that a majority of the complex I subunits including NDUFA2, NDUFA11, NDUFA12, NDUFB7, NDUFAF1 were substantially down-regulated (50%) after K-Ras^G12V^ induction (Table [3](#T3){ref-type="table"}), consistent with our previous finding that K-Ras activation inhibited activity of complex I \[[@R9]\]. K-Ras mutation is frequently observed in pancreatic cancer. Our immunohistochemistry analysis revealed that the majority of pancreatic carcinoma tumor tissues exhibited lower expression of NDUFAF1 compared with the normal tissue, suggesting that the down-regulation of NDUFAF1 is likely clinically relevant. Our results also suggest that disruption of complex I may play a major role in mediating suppression of mitochondrial respiration induced by K-Ras^G12V^. Although K-Ras represents the most frequent mutation observed in human cancer, several mutations to Ras can transform normal cells to cancer. While K-Ras mainly affects complex I assembly of mitochondrial respiratory chain, the effect of H-ras on mitochondrial respiration remain to be determined. Yang et al. showed that oncogenic H-ras^Q61L^ transformation caused defects of mitochondrial respiration in NIH-3T3 cells \[[@R21]\]. In contrast, Telang et al. demonstrated that introduction of activated H-ras^V12^ into immortalized human bronchial epithelial cells increased tricarboxylic acid cycle activity, oxygen consumption and energetic reliance on electron transport. These contrasting models suggest that the effect of oncogenic Ras on mitochondrial respiration may be context dependent.

However, the precise mechanism of inhibition of NDUFAF1 by K-Ras activation remains unclear at the present time. Ecsit is a cytosolic adaptor protein essential for inflammatory response. It has been reported that Ecsit can localize to mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly. The knockdown of Ecsit in mitochondria results in NDUFAF1 decrease and impaired complex I assembly \[[@R22]\]. Our previous studies have demonstrated translocation of K-Ras protein to mitochondria \[[@R9]\]. It would be interesting to further study the possible interaction of K-Ras and Ecsit and the effect on complex I assembly. In addition, the sequence analysis of human NDUFAF1 promoter revealed several putative TR4-hormone response elements and a chromatin immunoprecipitaiton (ChIP) assay has demonstrated NDUFAF1 is a directly target of TR4 \[[@R23]\]. The potential regulation of TR4 by K-Ras is worth further study.

The association of oncogenes and upregulation of glycolysis has been proposed for some time, although the underlying molecular mechanism still remains to be investigated. Because complex I initiates the electron transportation by oxidizing NADH to NAD^+^, here we found that inhibition of NDUFAF1 by activation of K-Ras resulted in accumulation of NADH. Because reoxidization of NADH is required to maintain proper NADH/NAD^+^ ratio and redox homeostasis, the accumulated NADH after K-Ras activation could be converted to NAD^+^ by redox-regulatory enzymes such as NAD(P)H Oxidase (NOX). Indeed, the regeneration of NAD^+^ is important to maintain active glycolysis. Our previous studies demonstrated that K-Ras activation or dysfunction of mitochondrial leads to up-regulation of NOX \[[@R9], [@R17]\]. Overexpression or elevated activity of NOX has also been reported in various cancer types including pancreatic cancer \[[@R17], [@R24], [@R25]\]. Although the focus of Warburg effect has been energy-centric, recent studies have suggested that the reprogrammed metabolism may be essential for macromolecular biosynthesis \[[@R26]\]. For instance, the tumor-specific form of pyruvate kinase (PKM2) increases the incorporation of glucose carbons into lipids \[[@R27]\]. Ying et al. reported that KrasG12D enhanced glycolytic flux into the pentose phosphate pathway without affecting TCA cycle \[[@R28]\]. Therefore, the decrease of NDUFAF1 observed in our model and pancreatic cancer specimen may indicate metabolic reprogramming driven by K-Ras oncogenic activation.

In summary, this study used SILAC analysis to reveal mitochondrial proteomic changes associated with mitochondrial dysfunction and metabolic alterations induced by oncogenic K-Ras^G12V^. Our results suggest that inhibition of mitochondrial respiratory chain complex I may significantly contribute to mitochondrial dysfunction and up-regulation of glycolytic activity during K-Ras-mediated transformation and metabolic "reprogramming". Suppression of NDUFAF1 expression and down regulation of other mitochondrial respiratory chain complex components may be important events contributing to K-Ras-induced mitochondrial dysfunction. The mechanisms by which K-Ras activation leads to down-regulation of mitochondrial respiratory chain components currently remain unclear and require further investigation.

METHODS {#s4}
=======

Cell culture and stable isotope labeling {#s4_1}
----------------------------------------

The doxycycline inducible T-Rex/293 cells were established as previously described \[[@R9]\]. T-Rex/K-Ras cells were cultured in Dulbecco\'s modified Eagle\'s medium supplemented with 10% tetracycline free fetal bovine serum. The medium without isotope and labeled with L-Arginine (R0) (84 mg/ml) or L-lysine (K0) (146 mg/ml) was considered as "light" (L) medium. The medium containing L-\[^13^C~6~\] arginine (R6) and L-4,4,5,5-D~4~-lysine (K4) (Sigma Aldrich) was considered as "medium" (M) medium. The medium containing L-\[^13^C~6~,^15^N~4~\] arginine (R10) and L-\[^13^C~6~,^15^N~2~\] lysine (K8) was considered as "heavy" (H) medium. T-Rex/K-Ras cells were cultured in SILAC medium for ten passages to ensure complete incorporation of isotopic amino acids. Cells were then induced by doxycycline for 24 hrs in M medium and 48 hrs in H medium. Cells without addition of doxycyline were cultured in L medium. HPDE cells and HPDE/K-Ras cells were cultured in DMEM/F12 medium.

Mitochondria isolation {#s4_2}
----------------------

Mitochondria of T-Rex/293 cells were isolated using Q-proteome Mitochondria Isolation kit (Qiagen). Briefly, cells were washed and re-suspended in lysis buffer and centrifuged at 1000 × g for 10 mins. The pellet was then re-suspended in Disruption Buffer and passed through a syringe 10 times, and re-centrifuged at 1000 × g for 10 mins to remove the nuclei, cell debris, and unbroken cells. The supernatant containing mitochondria and the microsomal fraction was centrifuged at 6000 × g for 10 mins to collect mitochondria pellet. After removal of the supernatant, the crude mitochondria pellet was re-suspended in Mitochondria Purification Buffer. The purified mitochondria were isolated by density gradient centrifugation. Finally, the mitochondria were re-suspended in lysis buffer containing 8 M urea, 4% CHAPS, 65 mM DTT, and 40 mM Tris and sonicated at 100 watts for 30 s. The sample was then centrifuged at 25,000 × g for 30 mins and the supernatant was collected as the mitochondrial protein lysates.

LC-MS analysis {#s4_3}
--------------

Same amount of mitochondria labeled with different isotypes were mixed and separated by one-dimensional SDS-PAGE. The gel was stained with coomassie blue R-250 and cut into 40 slices. The gel slices were then subjected to in-gel digestion with trypsin. Extraction and concentration of the samples for MS analysis were carried out as described previously \[[@R29], [@R30]\].

Trypsin-digested peptides were separated by HPLC system (Thermo Scientific). The sample was eluted onto a C~18~ nanocolumn (0.1 mm inner diameter × 10 cm long, Michrom Bioresources) using 0.1% formic acid in water as mobile phase A and 0.1% formic acid in 80% acetonitrile as mobile phase B. A linear gradient of 5--35% solvent B (90% acetonitrile with 0.1% formic acid) was eluted over 120 mins with a constant flow of 300 nl/min. The HPLC system was coupled to a linear ion trap-orbitrap hybrid mass spectrometer (LTQ-OrbitrapXL, Thermo Scientific) via a nanoelectrospray ion source (Proxeon Biosystems). The spray voltage was 1.2 kV, and the temperature of the heated capillary was 200°C. The full-scan mass range was from m/z 400--2000 with resolution 60,000 at m/z 400. The five most intense ions were sequentially isolated for fragmentation in the linear ion trap by collision-induced dissociation. Maximal filling times were 1,000 ms for the full scans and 150 ms for the MS/MS scans. The dynamic exclusion list was restricted to a maximum of 500 entries with a maximum retention period of 90 s and a relative mass window of 10 ppm.

MS data analysis {#s4_4}
----------------

The MS/MS peak list was generated by Xcalibur software (Thermo Scientific) and analyzed with MaxQuant (Version, 1.0.13.13). The output files were submitted to Mascot (Version 2.2, Matrix Science) for peptide and protein identification. Searches were conducted against target-decoy human MaxQuant (ipi.HUMAN.v3.52.decoy). Enzyme specificity was set to that of trypsin, allowing for N-terminal cleavage to proline and between aspartic acid and proline. Searches were performed with a MS tolerance of 20 ppm and a fragment tolerance of 0.5 Da. Carboxyamidomethylated cysteine was used as a fixed modification. Variable modifications included methionine oxidation and protein N-terminal acetylation. Peptides with minimum of 6 amino acids were allowed for analysis and proteins were identified if they had at least one unique peptide. The results were reported with 5% peptide false discovery rate and 1% protein false discovery rate. The posterior error probabilities (PEP, false hit probability given the peptide score and length) should be below or equal to 0.01. The sequences corresponding to the 760 protein entries were searched in the database.

Antibodies and RNA interference {#s4_5}
-------------------------------

The following antibodies were used for immunoblotting analysis: K-Ras, Cytochorme C and NDUFAF1 (Abcam), tubulin, VDAC and Bip (Cell Signaling). The siRNA (Ribobio, Guangzhou, China) target sequence for NDUFAF1 was 5′-GCAAGGAGATCACCAGAAA-3′. A non-specific scramble siRNA was used as control.

Transmission electron microscope {#s4_6}
--------------------------------

Samples were prepared as described previously \[[@R31]\]. Briefly, cells were fixed in 2.5% glutaraldehyde for 2 hours and 1% osmium tetroxide for another 1 hour. Cells were then dehydrated in a graded series of ethanol and embedded in spurr resin. Sections were prepared and examined with Morgagni transmission electron microscope (FEI).

Immunohistochemistry {#s4_7}
--------------------

Immunohistochemical staining for NDUFAF1 was performed on the pancreatic cancer tissue microarray (TMA, Shanghai Biochip, Shanghai, China) containing 80 pancreatic ductal carcinoma and 80 paired non-neoplastic pancreatic tissue samples. TMA was deparaffined and endogenous peroxidase activity was blocked with 3% hydrogen peroxidase. To unmask the immunoepitopes, the slides were immersed in EDTA (1 mmol/L, pH 8.0) and boiled for 15 minutes. The slides were incubated with NDUFAF1 antibody (Abcam, 1:100 dilution) overnightat at 4°C and with secondary antibody at room temperature for 30 mins. Finally, the slides were stained with 3, 3′-diaminobenzidine tetrahydrochloride (DAB) for signal detection and counterstained with 20% hematoxylin. The immunostaining scores were estimated according to the percentage of the staining intensity of the positive cells as described previously \[[@R32]\].

Flow cytometry analysis of reactive oxygen species (ROS) {#s4_8}
--------------------------------------------------------

Intracellular ROS (H~2~O~2~) contents were measured by incubating cells with 5 μM CM-DCFDA (Invitrogen) at 37°C for 1 h followed by detection using flow cytometry (Beckman Coulter). Intracellular superoxide level was measured by incubating cells with 5 μM MitoSOX (Invitrogen) at 37°C for 1 h before detection by flow cytometry analysis.

Analysis of oxygen consumption {#s4_9}
------------------------------

As previously described \[[@R33]\], 1 million cells were re-suspended in 1 ml culture medium pre-equilibrated with 21% oxygen and placed in a sealed respiration chamber (Oxytherm, Hansatech Instrument) to monitor oxygen consumption rate.

Metabolic measurements {#s4_10}
----------------------

Glucose uptake and lactate production were measured with Glucose Assay Kit II and Lactate Assay Kit II (Biovision) according to manufacturer\'s instructions. Aliquots of the medium were removed from cell culture and Glucose uptake and lactate production was determined by the concentration difference between samples and blank medium control. Cellular ATP and NADH contents were measured using the ATP Colorimetric Assay Kit and NADH Quantitation Kit (Biovision) respectively as described before \[[@R9]\].

Enzyme activity of mitochondria complex I {#s4_11}
-----------------------------------------

The activity of mitochondrial complex I was measured using Complex I Enzyme Activity Microplate Assay Kit (Abcam) according to manufacturer\'s instructions. Briefly, the mitochondrial proteins were extracted and added to the microplate. The complex I enzyme was immune captured within the wells of the microplate, and the activity was determined by the oxidation of NADH to NAD^+^. Complex I activity was measured by the increase in absorbance of the dye at 450 nm and shown as the changes in absorbance per minute.

Statistical analysis {#s4_12}
--------------------

Statistical difference between NDUFAF1 expression of benign and malignant pancreatic tissue on tissue microarray was analyzed by Fisher\'s exact test. All other statistical significant difference analyses were performed using a two-tailed Student\'s *t* test. The data are shown as means ± SD. *P* \< 0.05 was considered statistically significant.

SUPPLEMENTAL METHODS {#s5}
====================
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